Literature DB >> 26265896

McCune Albright syndrome in association with excessive GH secretion: case report.

Elif Özsu1, Gül Yeşiltepe Mutlu1, Filiz Mine Çizmecioğlu1, Şükrü Hatun1.   

Abstract

McCune-Albright Syndrome is a rare syndrome characterized with excessive function of peripheral endocrine organs and activating mutations of the stimulatory G protein alpha subunit are involved in the pathogenesis. The three main findings of the disease include hyperpigmented café au lait spots, fibrous dysplasia and increased endocrine functions and excessive secretion of growth hormone is observed in 21% of the patients. Clinical signs may be missed in these patients because of precocious puberty and craniofacial fibrous dysplasia. Since radiotherapy causes to sarcomatous changes and transsphenoidal surgery may cause to severe thickening in the cranial bones, they are not appropriate treatment options and medical treatment is recommended. Bromocriptine, cabergoline and octreotide or different combinations of these drugs are used in treatment and pegvisomant has also been used in recent years. Here, we present a male patient aged 12 years and 7 months to show gigantism as a rare clinical reflection of McCune-Albright Syndrome with an excessive height (197 cm), café au lait spots, growht hormone levels which could not be supressed with oral glucose tolerance test and increased prolactin levels.

Entities:  

Keywords:  Excess growth hormone; McCune Albright syndrome; cabergoline; somatostatin

Year:  2015        PMID: 26265896      PMCID: PMC4523984          DOI: 10.5152/tpa.2015.615

Source DB:  PubMed          Journal:  Turk Pediatri Ars


  13 in total

Review 1.  McCune-Albright syndrome: growth hormone and prolactin hypersecretion.

Authors:  Athanasios Christoforidis; Ilianna Maniadaki; Richard Stanhope
Journal:  J Pediatr Endocrinol Metab       Date:  2006-05       Impact factor: 1.634

2.  Clinical presentation of McCune-Albright syndrome in males.

Authors:  Malgorzata Wasniewska; Patrizia Matarazzo; Giovanna Weber; Gianni Russo; Maria Zampolli; Giuseppina Salzano; Giuseppina Zirilli; Silvano Bertelloni
Journal:  J Pediatr Endocrinol Metab       Date:  2006-05       Impact factor: 1.634

3.  McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patients.

Authors:  Françoise Galland; Peter Kamenicky; Hélène Affres; Yves Reznik; Dominique Pontvert; Yves Le Bouc; Jacques Young; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2006-09-19       Impact factor: 5.958

4.  Octreotide therapy of growth hormone excess in the McCune-Albright syndrome.

Authors:  S I Sherman; P W Ladenson
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

Review 5.  A case of pituitary adenoma associated with McCune-Albright syndrome.

Authors:  S Sakaki; S Yokoyama; K Mamitsuka; M Nakayama; M Goto; J Kuratsu
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

6.  Macroorchidism in an Indian boy with McCune-Albright syndrome.

Authors:  Vaishakhi T Rustagi; Vaman V Khadilkar; Anuradha V Khadilkar; Arun S Kinare
Journal:  Indian J Pediatr       Date:  2011-02-15       Impact factor: 1.967

7.  Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS.

Authors:  A Shenker; L S Weinstein; A Moran; O H Pescovitz; N J Charest; C M Boney; J J Van Wyk; M J Merino; P P Feuillan; A M Spiegel
Journal:  J Pediatr       Date:  1993-10       Impact factor: 4.406

Review 8.  Acromegaly with fibrous dysplasia: McCune-Albright Syndrome -- clinical studies in 3 cases and brief review of literature--.

Authors:  Anil Bhansali; Bhawani S Sharma; Polupoina Sreenivasulu; Paramjit Singh; Rakesh K Vashisth; Radharaman J Dash
Journal:  Endocr J       Date:  2003-12       Impact factor: 2.349

9.  Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome.

Authors:  Sunday O Akintoye; Caroline Chebli; Susan Booher; Penelope Feuillan; Harvey Kushner; Derek Leroith; Natasha Cherman; Paolo Bianco; Shlomo Wientroub; Pamela Gehron Robey; Michael T Collins
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

10.  McCune-Albright syndrome.

Authors:  Claudia E Dumitrescu; Michael T Collins
Journal:  Orphanet J Rare Dis       Date:  2008-05-19       Impact factor: 4.123

View more
  1 in total

1.  MicroRNA-200b inhibits pituitary tumor cell proliferation and invasion by targeting PKCα.

Authors:  Yuanchuan Wang; Xiaohong Yin; Long Zhao; Shun Li; Jie Duan; Renzhao Kuang; Junwei Duan
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.